|
Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome |
|
|
|
Title: |
Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome |
Author: |
Ghanem, Hady Cornelison, A. Megan Garcia-Manero, Guillermo Kantarjian, Hagop Ravandi, Farhad Kadia, Tapan Cortes, Jorge O'Brien, Susan Brandt, Mark Borthakur, Gautam Jabbour, Elias |
Appeared in: |
Clinical lymphoma myeloma and leukemia |
Paging: |
Volume 13 (2013) nr. S2 pages 6 p. |
Year: |
2013 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|